Pharmafile Logo

Mindstrong Health

- PMLiVE

La Roche-Posay launches global campaign to spotlight the visible and invisible impact of scars

‘Scars of Life’ aims to raise awareness of the psychological burden associated with skin conditions and scarring

- PMLiVE

From Burnout to Balance: New Campaign Focuses on the ‘Matters’ that are Really Affecting Our ‘Minds’ in Health Communications

Launched on World Mental Health Day, Minds on Matters aims to highlight mental wellbeing challenges while showcasing practical solutions and positive change

Fox&Cat

- PMLiVE

BMS, Takeda and Astex join AI training consortium

The initiative focuses on training AI models to aid in drug discovery and development

- PMLiVE

Takeda receives EC approval for Adcetris combination in Hodgkin lymphoma

The decision marks the second approval for an Adcetris-based regimen for front-line Hodgkin lymphoma

- PMLiVE

Takeda’s Adzynma approved by MHRA for rare blood clotting disorder cTTP

The enzyme replacement therapy is now the first treatment approved in the UK for this patient population

- PMLiVE

Takeda receives CHMP recommendation for Adcetris in Hodgkin lymphoma

The EC will review the committee’s positive opinion as it makes a decision on Adcetris in this indication

- PMLiVE

Takeda receives NICE recommendation for Adcetris combination in Hodgkin lymphoma

Around 800 people in the UK are diagnosed with late-stage disease every year

- PMLiVE

Takeda/Protagonist share positive phase 3 results for rusfertide in rare blood cancer

Up to 160,000 people in the US are affected by polycythaemia vera

- PMLiVE

How can a digital PR strategy elevate your company’s profile? A spotlight on mental health

In the ever-evolving healthcare media landscape, Digital PR bridges the traditional benefits of reach, share of voice, and sentiment with the power of Search Engine Optimization (SEO)—delivering both meaningful connections...

EatMoreFruit

- PMLiVE

Takeda and EU Innovative Health Initiative launch Crohn’s disease prevention study

Approximately three million people in Europe are affected by inflammatory bowel disease

One person comforting another

Caring for patients’ mental health in clinical trials

We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.

Cuttsy + Cuttsy

- PMLiVE

Takeda’s mezagitamab shows promise in immune thrombocytopenia

The rare immunoglobulin-mediated autoimmune disease affects four in every 100,000 people annually

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links